Literature DB >> 16146731

Contribution of anti-inflammatory/immune suppressive processes to the pathology of sepsis.

Mario Perl1, Chun-Shiang Chung, Megan Garber, Xin Huang, Alfred Ayala.   

Abstract

Sepsis is the leading cause of death in critically ill patients in the United States. It is associated with enormous expenditures within the health care system and despite substantial human, medical and fiscal resources directed at this clinical entity we have only had a modest effect on the septic patient's long-term survival. However, extensive studies over the last few decades have begun to reveal important pathophysiological processes around which a few promising therapeutic strategies with potential benefits may be derived. It is generally believed, that the body reacts to a septic challenge with an intense hyper-inflammatory response, designed to eliminate the underlying pathogen. However, along with and in response to the intense pro-inflammatory reaction, mechanisms fall into place to counter regulate (control) this initial response, typically resulting in a down regulation of the inflammatory response. This frequently results in dysfunction of various immunological conditions and may result in the inability to ward off the infection and consecutively lead to multiple organ dysfunction, multiple organ failure and death. It is the aberrant development of this anti-inflammatory/ immunosuppressive response, in which it is important to expand our understanding of pathological components to develop potential remedy. Upon this background this review aims to provide an overview on the pathophysiological mechanisms which initiate or maintain the down regulation of the immune response to a septic challenge and which might be a starting point for the development of therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16146731     DOI: 10.2741/1797

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  18 in total

1.  No good deed goes unpunished!

Authors:  Alfred Ayala; Doreen E Wesche-Soldato; Megan Garber; Ryan Swan; Mario Perl
Journal:  Intensive Care Med       Date:  2006-04-01       Impact factor: 17.440

Review 2.  Eicosanoid regulation of pulmonary innate immunity post-hematopoietic stem cell transplantation.

Authors:  Megan N Ballinger; Tracy R McMillan; Bethany B Moore
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Jan-Feb       Impact factor: 4.291

3.  Combination therapy with thymosin alpha1 and dexamethasone helps mice survive sepsis.

Authors:  Xiao-song Xiang; Ning Li; Yun-zhao Zhao; Qiu-rong Li; Jie-shou Li
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

4.  MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis.

Authors:  Clara McClure; Laura Brudecki; Donald A Ferguson; Zhi Q Yao; Jonathan P Moorman; Charles E McCall; Mohamed El Gazzar
Journal:  Infect Immun       Date:  2014-06-30       Impact factor: 3.441

5.  Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions.

Authors:  Caroline N Jones; Jesmond Dalli; Laurie Dimisko; Elisabeth Wong; Charles N Serhan; Daniel Irimia
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

6.  Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve.

Authors:  Rongqian Wu; Weifeng Dong; Xiaoxuan Cui; Mian Zhou; H Hank Simms; Thanjavur S Ravikumar; Ping Wang
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

Review 7.  Basic principles and emerging concepts in the redox control of transcription factors.

Authors:  Regina Brigelius-Flohé; Leopold Flohé
Journal:  Antioxid Redox Signal       Date:  2011-04-05       Impact factor: 8.401

8.  Treatment with Fms-like tyrosine kinase 3 ligand reverses lung dendritic cell immunoparalysis and ameliorates zymosan-induced secondary lung injury in mice.

Authors:  H W Wang; W Yang; J Y Lu; G Tian; F Li; X H Wang; J R Kang; Y Yang
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

Review 9.  A novel role for coinhibitory receptors/checkpoint proteins in the immunopathology of sepsis.

Authors:  Eleanor A Fallon; Bethany M Biron-Girard; Chun-Shiang Chung; Joanne Lomas-Neira; Daithi S Heffernan; Sean F Monaghan; Alfred Ayala
Journal:  J Leukoc Biol       Date:  2018-02-02       Impact factor: 4.962

10.  N-acetylcysteine administration is associated with reduced activation of NF-kB and preserves lung dendritic cells function in a zymosan-induced generalized inflammation model.

Authors:  Hong-Wei Wang; Wen Yang; Jiang-Yang Lu; Fei Li; Jun-Zhong Sun; Wen Zhang; Nan-Nan Guo; Lei Gao; Jia-Rui Kang
Journal:  J Clin Immunol       Date:  2012-12-16       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.